最新药物分子砌块-2021/08 - 乐研试剂

搜索

购物车

最新药物分子砌块-2021/08 2021/08/06 16:16:03

新品推荐 - 2021 年 08 月

Antibody-Drug conjugates (ADCs) have become a promising targeted therapy strategy that combines the specificity, favorable pharmacokinetics and biodistributions of antibodies with the destructive potential of highly potent drugs^[1].
ADCs consist of a desirable monoclonal antibody, an active cytotoxic drug and an appropriate linker. The monoclonal antibodies lead the drug precursors to the target cancer cells, in which the prodrugs can be chemically or enzymatically converted to drugs in their active forms . Conjugating cytotoxins to monoclonal antibodies that specifically tie to tumor cell surface antigens enables the drugs to be target-delivered to cancer cells and leaves normal cells unaffected. More important, many of the cytotoxic drugs that are too toxic for use in traditional chemotherapy can also be used in the construction of antibody-drug conjugates. The linkers are essential parts of antibody-drug conjugates, which account for stability in circulation,good pharmacokinetics and efficient release of toxic drugs in the tumor cells^[2,3,4].

A series of medicinal products containing 1,3,4-oxadiazole has been firmly incorporated in medical practice.

产品编号: 1099391

CAS: 138529-46-1
产品编号: 1175659

CAS: 1433997-01-3
产品编号: 1178252

CAS: 1537170-85-6
产品编号: 1175811

CAS:2222981-71-5
产品编号: 1054454

CAS: 159857-81-5
产品编号: 1175649

CAS: 2149584-03-0

免费热线：400-821-0725

官方网址： www.leyan.com 技术支持邮箱： tech@leyan.com 产品咨询邮箱： product@leyan.com

声明：乐研产品仅用于科学研究，我们不为任何个人用途提供产品与服务。

上一篇：最新药物分子砌块-2021/08 下一篇：最新药物分子砌块-2021/08

80000+分子砌块

现货供应

10年研发经验

专业护航

7天无理由退换

售后无忧

100%质量检测

品质保障

100%产品包邮

无需凑单

上海皓鸿生物医药科技有限公司

关于乐研
会员与积分

订购指南
文档和参考资料

售后和支持

尊敬的乐研客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

上海企业高校江苏企业高校浙江企业高校北京企业高校天津企业高校河北河北广东企业高校深圳深圳福建福建山东山东山西山西安徽安徽湖北湖北湖南湖南江西江西川渝企业高校陕西陕西甘肃甘肃黑龙江黑龙江吉林吉林辽宁辽宁云南云南贵州贵州广西广西海南海南宁夏宁夏河南河南内蒙古内蒙古新疆新疆青海青海